The rivalry between Pfizer and MSD in pneumococcal vaccines has dialled up a notch with the FDA approval of MSD’s new shot Capvaxive, the first to be aimed specifically at adults. The 21-valent ...

New phase 2b/3 trial results with MSD's experimental respiratory syncytial virus (RSV) antibody clesrovimab have fired a shot across the bows of AstraZeneca and Sanofi, currently predicting ...

Two distributors in the foodservice, JanSan and industrial packaging sectors announced on Aug. 11 that they plan to merge in a deal positioned to be a significant milestone for the industry. Imperial ...

Automotive solutions provider Continental announced its intention to separate from its ContiTech business, with a sale being the most likely option. On April 8, Continental said that it is evaluating ...